Determinants of interferon β efficacy in patients with multiple sclerosis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Determinants of interferon β efficacy in patients with multiple sclerosis
Authors
Keywords
-
Journal
Nature Reviews Neurology
Volume 7, Issue 4, Pages 221-228
Publisher
Springer Nature
Online
2011-03-03
DOI
10.1038/nrneurol.2011.22
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Effect of Neutralizing Antibodies to Interferon Beta That Persist Long After Cessation of Therapy for Multiple Sclerosis
- (2010) Laura F. van der Voort ARCHIVES OF NEUROLOGY
- Transfer of myxovirus-protein-A mRNA assay for interferon-β bioactivity measurement in multiple sclerosis patients to routine laboratory practice. A 4-year experience
- (2010) Cinzia Zanotti et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Imaging biomarkers in multiple sclerosis
- (2010) M. Filippi et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis
- (2010) Chris H Polman et al. LANCET NEUROLOGY
- T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
- (2010) Robert C Axtell et al. NATURE MEDICINE
- Breakthrough disease during interferon- therapy in MS: No signs of impaired biologic response
- (2010) D. Hesse et al. NEUROLOGY
- Spontaneous MxA mRNA level predicts relapses in patients with recently diagnosed MS
- (2010) L. F. van der Voort et al. NEUROLOGY
- A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
- (2010) Gavin Giovannoni et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
- (2010) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- IFN-β pharmacogenomics in multiple sclerosis
- (2010) Koen Vandenbroeck et al. PHARMACOGENOMICS
- Magnetic resonance imaging as a potential surrogate for relapses in multiple sclerosis: A meta-analytic approach
- (2009) Maria Pia Sormani et al. ANNALS OF NEUROLOGY
- Defining Multiple Sclerosis Treatment Response With Magnetic Resonance Imaging
- (2009) Paul S. Giacomini ARCHIVES OF NEUROLOGY
- Genome-wide Scan of 500 000 Single-Nucleotide Polymorphisms Among Responders and Nonresponders to Interferon Beta Therapy in Multiple Sclerosis
- (2009) Manuel Comabella et al. ARCHIVES OF NEUROLOGY
- A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis
- (2009) M. Comabella et al. BRAIN
- Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta
- (2009) Giancarlo Comi CLINICAL THERAPEUTICS
- One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis
- (2009) L. Prosperini et al. EUROPEAN JOURNAL OF NEUROLOGY
- Lack of interferon-beta bioactivity is associated with the occurrence of relapses in multiple sclerosis
- (2009) L. F. van der Voort et al. EUROPEAN JOURNAL OF NEUROLOGY
- Antibodies against interferon-beta in multiple sclerosis
- (2009) Nina Karin Aarskog et al. JOURNAL OF NEUROIMMUNOLOGY
- Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
- (2009) G Comi et al. LANCET
- Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis
- (2009) Richard A Rudick et al. LANCET NEUROLOGY
- Glypican 5 is an interferon-beta response gene: a replication study
- (2009) MDC Cénit et al. Multiple Sclerosis Journal
- Measures in the first year of therapy predict the response to interferon β in MS
- (2009) J Río et al. Multiple Sclerosis Journal
- Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode
- (2009) DS Goodin et al. Multiple Sclerosis Journal
- Predicting responders to therapies for multiple sclerosis
- (2009) Jordi Río et al. Nature Reviews Neurology
- Absence of MxA induction by interferon in patients with MS reflects complete loss of bioactivity
- (2009) D. Hesse et al. NEUROLOGY
- Multiple sclerosis pharmacogenomics: Maximizing efficacy of therapy
- (2009) D. J. Pappas et al. NEUROLOGY
- Effect of neutralizing antibodies on biomarker responses to interferon beta: The INSIGHT study
- (2009) A. R. Pachner et al. NEUROLOGY
- Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple Sclerosis
- (2008) Esther Byun et al. ARCHIVES OF NEUROLOGY
- Heterogeneity in Response to Interferon Beta in Patients With Multiple Sclerosis
- (2008) Annie W. Chiu ARCHIVES OF NEUROLOGY
- Genomic effects of once-weekly, intramuscular interferon-β1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients
- (2008) Bianca Weinstock-Guttman et al. JOURNAL OF NEUROIMMUNOLOGY
- Interferon-β bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice
- (2008) LF van der Voort et al. Multiple Sclerosis Journal
- Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients
- (2008) J Río et al. Multiple Sclerosis Journal
- Predictive markers for response to interferon therapy in patients with multiple sclerosis
- (2008) S. Malucchi et al. NEUROLOGY
- Pharmacogenomics of IFN-β in multiple sclerosis: towards a personalized medicine approach
- (2008) Saskia Vosslamber et al. PHARMACOGENOMICS
- Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
- (2008) Lisa G. M. van Baarsen et al. PLoS One
- In vivo bioactivity of interferon-beta in multiple sclerosis patients with neutralising antibodies is titre-dependent
- (2007) A Sominanda et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started